Institutional members access full text with Ovid®

Share this article on:

Patient Management Problem-Preferred Responses

Fox, Robert J. MD, FAAN; Rae-Grant, Alexander D. MD, FRCP(C)

doi: 10.1212/01.CON.0000433274.02899.df
CME

Address correspondence to Dr Robert J. Fox, Mellen Center for MS, Cleveland Clinic, 9500 Euclid Ave, U-10, Cleveland, OH 44195, foxr@ccf.org.

Relationship Disclosure: Dr Fox serves as a consultant for Allozyne, Inc, Avanir Pharmaceuticals, Inc, Biogen Idec, Novartis, Questcor Pharmaceuticals, Inc, and Teva Neuroscience, and receives research support from Novartis. Dr Rae-Grant has served as a speaker for Avanir Pharmaceuticals, Inc, Biogen Idec, Novartis, and Teva Neuroscience.

Unlabeled Use of Products/Investigational Use Disclosure: Drs Fox and Rae-Grant report no disclosures.

© 2013 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website